Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randy A Taplitz

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
British Journal of Haematology|February 17, 2022
Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agentSandy On, Carolyn G Rath, Michelle Lan, et al.
Iscience|July 18, 2022
Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variantsFlavia Chiuppesi, John A Zaia, Katelyn Faircloth, et al.
The New England Journal of Medicine|February 14, 2024
HIV-1 Remission after Allogeneic Hematopoietic-Cell TransplantationJana K Dickter, Ahmed Aribi, Angelo A Cardoso, et al.
The Lancet. Microbe|March 15, 2022
Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trialFlavia Chiuppesi, John A Zaia, Paul H Frankel, et al.
Vaccines|September 28, 2023
Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular TherapyFlavia Chiuppesi, Sandra Ortega-Francisco, Miguel-Angel Gutierrez, et al.
Science (New York, N.Y.)|November 6, 2010
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation, Florencia Pereyra, Xiaoming Jia, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
British Journal of Haematology|February 17, 2022
Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agentSandy On, Carolyn G Rath, Michelle Lan, et al.
Iscience|July 18, 2022
Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variantsFlavia Chiuppesi, John A Zaia, Katelyn Faircloth, et al.
The New England Journal of Medicine|February 14, 2024
HIV-1 Remission after Allogeneic Hematopoietic-Cell TransplantationJana K Dickter, Ahmed Aribi, Angelo A Cardoso, et al.
The Lancet. Microbe|March 15, 2022
Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trialFlavia Chiuppesi, John A Zaia, Paul H Frankel, et al.
Vaccines|September 28, 2023
Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular TherapyFlavia Chiuppesi, Sandra Ortega-Francisco, Miguel-Angel Gutierrez, et al.
Science (New York, N.Y.)|November 6, 2010
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation, Florencia Pereyra, Xiaoming Jia, et al.
Pageof 3